Two billionaire investors take aim at struggling Bausch Health — here's our take

We're pleased to see a shakeup at Bausch Health and its majority-owned recent IPO Bausch + Lomb, but we're not ready to buy more yet.

from US Top News and Analysis https://ift.tt/D73xUvN
https://ift.tt/u5wUDSH